Severe COVID-19 can manifest as multiorgan dysfunction with pulmonary involvement
being the most common and prominent. As more reports emerge in the literature, it appears …

Acute and chronic kidney disease encompasses a complex set of diseases that can both
lead to, and result from, cancer. In particular, kidney disease can arise from the use of …

Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

Background Reports show that AKI is a common complication of severe coronavirus disease
2019 (COVID-19) in hospitalized patients. Studies have also observed proteinuria and …

Thrombotic microangiopathy (TMA) is a condition characterized by thrombocytopenia and
microangiopathic hemolytic anemia (MAHA) with varying degrees of organ damage in the …

Drug-induced thrombotic microangiopathy (DITMA) represents 10%–13% of all thrombotic
microangiopathy (TMA) cases and about 20%–30% of secondary TMAs, just behind …

Overactivation of the complement alternative pathway drives the pathogenesis of primary
atypical hemolytic uremic syndrome (aHUS). Genetically‐determined or acquired …

Conventional chemotherapies remain the mainstay of treatment for many malignancies.
Kidney complications of these therapies are not infrequent and may have serious …

The prevalence of CKD may be higher in patients with cancer than in those without due to
the addition of cancer-specific risk factors to those already present for CKD. In this review …

Microangiopathic hemolytic anemia (MAHA) with thrombocytopenia, suggests a thrombotic
microangiopathy (TMA), linked with thrombus formation affecting small or larger vessels. In …